Vassiliki Kalotychou

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

Narjes Nasiri‐Ansari, Chrysa Nikolopoulou, Katerina Papoutsi et al. · International Journal of Molecular Sciences · 2021 · 293 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant–antioxidant status

Anna Gizi, Ioannis Papassotiriou, Filia Apostolakou et al. · Blood Cells Molecules and Diseases · 2011 · 113 citations

Life Sciences, Hematology, Redox Biochemistry +14

Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).

Yannis Rombos, Revekka Tzanetea, K. Konstantopoulos et al. · PubMed · 2000 · 59 citations

Medicine, Hematology, Pharmacology +17

Clinical and laboratory effects of long‐term administration of hydroxyurea to patients with sickle‐cell/β‐thalassaemia

Ersi Voskaridou, Vassiliki Kalotychou, Dimitris Loukopoulos · British Journal of Haematology · 1995 · 56 citations

Medicine, Hematology, Pharmacology +12

Reduction of the Clinical Severity of Sickle Cell/β-Thalassemia with Hydroxyurea: The Experience of a Single Center in Greece

Dimitris Loukopoulos, Ersi Voskaridou, Vassiliki Kalotychou et al. · Blood Cells Molecules and Diseases · 2000 · 43 citations

Medicine, Health Sciences, Hematology +11